Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biotin Masking of hCG Abuse
NCT05450900Phase 1Completed
- Sponsor
- Sports Medicine Research and Testing Laboratory
- Start
- Oct 2022
- Primary completion
- Feb 2023
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial (2 arms), sponsored by Sports Medicine Research and Testing Laboratory. Primary endpoints: Urinary human chorionic gonadotropin and biotin concentrations at 6 months and HPT-related hormone measurements in serum; biotin measurements in serum at 6 months. Started Oct 2022; status: completed.
Beyond the preview
Go deeper on NCT05450900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05450900.